Quantum Engine™
A NEW PARADIGM FOR CANCER TREATMENT
GenomeFrontier is committed to develop state-of-the-art products and platforms for production of next-generation gene-modified cell therapies that are highly effective, specific, persistent, and safe.
We accomplish this through our Quantum Engine™, which integrates four proprietary platforms: Quantum Nufect™, Quantum pBac™, iCellar™, and G-Tailor™. The platforms improve vector delivery, therapeutic gene integration, cell expansion capacity, and gene design, respectively.